Literature DB >> 7682106

In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: an immunohistochemical study.

P Vandenberghe1, J Delabie, M de Boer, C De Wolf-Peeters, J L Ceuppens.   

Abstract

B7/BB1 is a physiological ligand for CD28, a receptor expressed on a major subset of T lymphocytes. B7/BB1 has been shown to be expressed on human blood dendritic cells and on in vitro activated (but not resting) B cells and monocytes. Ligation of CD28 with B7/BB1 up-regulates cytokine production and prevents the induction of anergy in T cells activated through TCR/CD3. We examined the in situ expression of B7/BB1 by immunohistochemistry with a novel mAb B7-24. Dendritic cells in skin (Langerhans cells), lymph node sinuses (veiled cells), and T cell zones of spleen and lymph nodes (interdigitating dendritic cells) were strongly positive for B7/BB1. B7/BB1 was also present on fetal thymus dendritic cells located at the cortico-medullar junction and the medulla, but absent in normal adult thymuses. Resident macrophages and endothelial cells did not stain, but in granulomatous inflammations B7/BB1 was found on macrophages and epitheloid cells. A subset of B immunoblasts and of germinal center B cells in lymph node and spleen was also found to express B7/BB1. Our findings on the distribution of B7/BB1 expression in tissues, in particular its expression on professional antigen-presenting cells, further substantiate the putative co-stimulatory role of B7/BB1 in T cell activation in vivo. The presence of B7/BB1 in fetal but not adult thymic medulla suggests a role for B7/BB1 in thymocyte maturation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682106     DOI: 10.1093/intimm/5.3.317

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  13 in total

1.  The western-type diet induces anti-HMGB1 autoimmunity in Apoe(-/-) mice.

Authors:  Yue Pan; Hanzhong Ke; Zhaoqi Yan; Yajun Geng; Nathan Asner; Sunil Palani; Gnanasekar Munirathinam; Subramanyam Dasari; Karin C Nitiss; Sarah Bliss; Priyanka Patel; Hongming Shen; Catherine A Reardon; Godfrey S Getz; Aoshuang Chen; Guoxing Zheng
Journal:  Atherosclerosis       Date:  2016-05-19       Impact factor: 5.162

Review 2.  Participation of blood vessel cells in human adaptive immune responses.

Authors:  Jordan S Pober; George Tellides
Journal:  Trends Immunol       Date:  2011-10-24       Impact factor: 16.687

3.  Human CTLA-4 is expressed in situ on T lymphocytes in germinal centers, in cutaneous graft-versus-host disease, and in Hodgkin's disease.

Authors:  K Vandenborre; J Delabie; M A Boogaerts; R De Vos; K Lorré; C De Wolf-Peeters; P Vandenberghe
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

4.  Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.

Authors:  K S Hathcock; G Laszlo; C Pucillo; P Linsley; R J Hodes
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

5.  Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness.

Authors:  D M Harlan; H Hengartner; M L Huang; Y H Kang; R Abe; R W Moreadith; H Pircher; G S Gray; P S Ohashi; G J Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

6.  Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.

Authors:  J H Vingerhoets; G L Vanham; L L Kestens; G G Penne; R L Colebunders; M J Vandenbruaene; J Goeman; P L Gigase; M De Boer; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

Review 7.  Treatment options--commentary.

Authors:  R J Arceci
Journal:  Br J Cancer Suppl       Date:  1994-09

8.  Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand.

Authors:  D C Parker; D L Greiner; N E Phillips; M C Appel; A W Steele; F H Durie; R J Noelle; J P Mordes; A A Rossini
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

9.  Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate.

Authors:  L M Wetzler; Y Ho; H Reiser; L W Wetzler
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

10.  The combination of anti-B7 monoclonal antibody and cyclosporin A induces alloantigen-specific anergy during a primary mixed lymphocyte reaction.

Authors:  S W Van Gool; M de Boer; J L Ceuppens
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.